The short answer
Gymnema may change insulin requirements, but added clinical hypoglycemia with insulin lispro protamine has not been established. The inspected insulin study does not identify either Humalog premix.
What this answer covers
Gymnema sylvestre leaf extract GS4; other preparations differ. Humalog premixes contain both protamine and soluble lispro.
- Supplement or preparation
- Gymnema sylvestre
- Medication ingredient
- insulin lispro protamine, human
An insulin study suggests a treatment effect
A small study added GS4 leaf extract to insulin and reported lower insulin requirements and glucose measures. This supports reviewing use when treatment changes.
The exact premix was not identified
The abstract does not verify insulin lispro protamine or a clinical hypoglycemia rate. A change in insulin requirements cannot establish a fixed dose reduction for everyone.
The extract boundary matters
The study used a particular water-soluble leaf extract. Other products may differ, and its proposed explanation involving endogenous insulin is not proof of pancreatic regeneration.
Keep the insulin plan supervised
Discuss the exact product and amount with the diabetes team and follow your glucose-monitoring and low-glucose treatment plan. Do not change the premix dose yourself. No protective spacing interval follows from the study.
Evidence and practical considerations
Side effects & toxicity
Indirect insulin requirement findings lack verified lispro-premix exposure and clinical hypoglycemia incidence.
- Exact scope
- Gymnema sylvestre leaf extract GS4; other preparations differ. Humalog premixes contain both protamine and soluble lispro. with Insulin lispro protamine human RxCUI314684 IN within HumalogMix75/25 or50/50, SC only.
- Medication form and route
- subcutaneous insulin premix; oral supplement
What remains uncertain
- Whole-product evidence does not isolate protamine component; no exact event rate or universal dose change.
Factors that may matter: Fixed ratio; Meals; Product; Dose; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults prescribed the fixed lispro premix
Hypoglycemia can be severe; niacin can reduce glucose lowering. Fixed ratio precludes separate basal/prandial dose adjustments. Inject within15minutes before a meal as labeled.
How this applies: RxCUI314684 IN insulin lispro protamine, human, as component of specified Humalog mixture.
Whole-product evidence does not isolate protamine component, compare every premix or apply to soluble lispro alone. No herb-specific adverse-event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults prescribed the fixed lispro premix
Hypoglycemia can be severe; niacin can reduce glucose lowering. Fixed ratio precludes separate basal/prandial dose adjustments. Inject within15minutes before a meal as labeled.
How this applies: RxCUI314684 IN insulin lispro protamine, human, as component of specified Humalog mixture.
Whole-product evidence does not isolate protamine component, compare every premix or apply to soluble lispro alone. No herb-specific adverse-event rate.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 27insulin-dependent diabetes patients given GS4.
Insulin needs and glucose measures decreased with GS4; glycosylated measures remained above controls.
How this applies: Indirect for insulin lispro protamine within the labeled Humalog mixtures; original preparation and clinical endpoint retained.
Insulin type and exact premix not established in abstract; no clinical hypoglycemia rate or tested spacing. Beta-cell recovery remains hypothetical.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact protamine-lispro ingredient article with fixed-combination and original case-report limits. | |
| Research summary published |
Article revision: 68a7cb037a7cf716
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.